Risk of Cancer After Growth-Hormone Treatment

The Lancet - United Kingdom
doi 10.1016/s0140-6736(02)09561-2
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Elsevier BV

Related search

Growth Hormone Treatment and Risk of Malignancy

Korean Journal of Pediatrics
Child HealthPediatricsPerinatology
2015English

Growth Hormone Treatment in Children After Cranial Trradiation

Pediatric Research
Child HealthPediatricsPerinatology
1988English

Hormone Treatment Plus Radiation Delays Growth of Prostate Cancer

BMJ
2008English

Risk of Endometrial Cancer After Tamoxifen Treatment of Breast Cancer

The Lancet
Medicine
1994English

Cancer Risk After Cyclophosphamide Treatment in Idiopathic Membranous Nephropathy

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2014English

Cardioprotective Effects of Growth Hormone-Releasing Hormone Agonist After Myocardial Infarction

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2010English

Treatment of Hormone‐Resistant Prostate Cancer

Oncologist
Cancer ResearchMedicineOncology
1997English

Suppressed Spontaneous Secretion of Growth Hormone in Girls After Treatment for Acute Lymphoblastic Leukaemia.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1989English

Decrease in Telomerase Activity in U-87mg Human Glioblastomas After Treatment With an Antagonist of Growth Hormone-Releasing Hormone

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy